All posts by imreal

GeBBS Ranked #3 in the Top 10 on Modern Healthcare’s List of Largest Revenue-Cycle Management Firms 2022


We are proud to be ranked #3 by modern healthcare on its list of largest revenue cycle management firms.

GeBBS Healthcare Solutions, Inc.(ChrysCapital portfolio company), a leading provider of revenue-cycle management (RCM) and risk adjustment solutions for healthcare providers and payers, announced today that it has again been named to Modern Healthcare‘s Top 10 List of Largest Revenue-Cycle Management Companies.

This is the seventh time that GeBBS has been ranked on this list since its inaugural ranking in 2016. This year, the company climbed to the third spot compared to the sixth rank it received in 2021.

“With our transformative approach of automate, innovate, transform, we help our healthcare provider clients achieve financial improvements, especially amid the revenue pressures brought on by the pandemic and the ongoing challenges health systems face in growing their top lines,” said Milind Godbole, CEO & Managing Director of GeBBS Healthcare Solutions. “We are proud to be ranked #3 by modern healthcare on its list of largest revenue cycle management firms. Our continued growth is directly attributed to our valued employees and the relationships we have built with our esteemed clients.”

Modern Healthcare’s Largest Revenue Cycle Management Firms list recognizes the nation’s top revenue cycle management companies ranked by total number of contracts in 2021. The list includes nation’s top firms that have dedicated practice areas and staff to address the needs of the healthcare revenue cycle process. Participating companies report a breakdown of contracts between comprehensive revenue cycle and partial services.

About GeBBS

GeBBS Healthcare Solutions is a KLAS rated leading provider of Revenue Cycle Management (RCM) services and Risk Adjustment solutions. GeBBS’ innovative technology, combined with over 12000+strong global workforce, helps clients improve financial performance, adhere to compliance, and enhance the patient experience. Headquartered in Los Angeles, CA, GeBBS has won numerous accolades for its medical coding outsourcing and medical billing outsourcing, including being ranked in Modern Healthcare’s Top 20 Largest RCM Firms, Black Book Market Research’s Top 20 RCM Outsourcing Services, and Inc. 5000’s fastest growing private companies in the U.S. For more information, please visit http://www.gebbs.com

About Modern Healthcare

Modern Healthcare is the industry’s leading source of healthcare business and policy news, research, and information. We report on important healthcare events and trends, as they happen, through our weekly print magazine, websites, e-newsletters, mobile products, and events. Our readers use that information to make informed business decisions and lead their organizations to success. It’s for this reason that Modern Healthcare magazine is ranked No. 1 in readership among healthcare executives and deemed a “must-read” by the who’s who in healthcare. Modern Healthcare leads the market in editorial excellence and is honored to receive awards from ASBPE, ASHPE American Business Media, Trade Association and Business Publications International and the Association of Health Care Journalists, affirming Modern Healthcare’s status as the best source for healthcare business and policy news, research, and information.

For more information contact:

Tyler Cowart

310-953-4444 ext. 214

tyler.cowart@gebbs.com

Share article on social media or email:

The National Certification Corporation (NCC) is pleased to announce the launch of the public service campaign, “Certified Nurses Make a Difference”


Certified Nurses Make a Difference through every stage of your life.

Certified Nurses Make a Difference through every stage of your life.

Certification is a choice! Certified nurses have chosen to go beyond licensure…they have specialized skills and advanced knowledge, including the latest developments in patient care.

Nurses have long been recognized as the most trusted health care providers, and in the last two years the public has been especially aware of their courage, commitment, knowledge, resilience, and advocacy during a time of adversity and fear.

Certification is a choice! Certified nurses have chosen to go beyond licensure to validate their specialty knowledge through national third-party examinations. They have specialized skills and advanced knowledge, including the latest developments in patient care.

NCC supports the commitment and expertise of certified healthcare professionals and has engaged in several public awareness campaigns to bring much-deserved recognition to professional certification. (YouTube.com/user/NCCcertifies)

Distribution for our national PSA campaign “Certified Nurses Make a Difference” includes broadcast and cable TV, Connected TV, Marketed YouTube, Hulu Streaming, News Site Video Pre-Roll along with National Network Commercials in major designated market areas across the country and is expected to generate over 200 million impressions. To view this PSA, please visit CertifiedNurses.org or our YouTube station above. To download a broadcast quality copy, click here. https://psaconnect.c360m.com/ncc/

The National Certification Corporation (NCC) has promoted quality health care by providing nationally accredited certification opportunities and continuing education since 1975 and has awarded certifications to over 195,000 licensed health care professionals. NCC certified nurses and nurse practitioners provide expert care in the obstetric, neonatal and women’s health care specialties.

This PSA campaign is a joint effort by NCC, and the other nationally accredited organizations listed below.

American Board for Certification of Gastroenterology Nurses

American Board of Neuroscience Nursing

American Board of Nursing Specialties

Board of Certification for Emergency Nursing

Certification Board for Diabetes Care and Education

Medical-Surgical Nursing Certification Board

National Board on Certification and Recertification of Nurse Anesthetists

National Certification Corporation

Oncology Nursing Certification Corporation

Orthopaedic Nurses Certification Board

PSI Services, Credentialing

Wound, Ostomy and Continence Nursing Certification Board

Share article on social media or email:

VIC Foundry Awarded an NIH Grant for Development of Instrument for Ultrafast Detection of Protein Biomarkers


News Image

“We are excited to receive NIH funding for this high-impact technology that can help researchers develop new diagnostics and treatments across a wide range of conditions,” said Calvin Goforth, CEO of VIC Foundry.

VIC Foundry, in collaboration with the University of Buffalo, has been awarded a $259,000 grant from the National Institutes of Health (NIH) through the Small Business Technology Transfer (STTR) program. STTR grants support research and development to de-risk new technologies that have significant commercial potential.

The grant will help VIC Foundry develop a microwave microreactor for in-situ capture and digestion of target proteins, leveraging an extraordinary acceleration effect of a unique microwave resonator on the binding and pyrolytic reaction rates. The microreactor can be directly coupled to mass spectrometry for ultrafast (near real-time), unambiguous detection of protein biomarkers.

“We are excited to receive NIH funding for this high-impact technology that can help researchers develop new diagnostics and treatments across a wide range of conditions,” said Calvin Goforth, CEO of VIC Foundry.

Proteins are the most important and established class of biomarkers for clinical diagnosis, monitoring, and management. In diagnosis, risk stratification, and management of many life-threatening diseases/conditions such as myocardial infarction, every minute counts and unambiguous detection of relevant protein biomarkers is crucial. Unfortunately, the workflow of current approach–mass spectrometry–is bottlenecked by the sample preparation process. The microwave microreactor technology will address this significant limitation.

The proposed technology and product will streamline the workflow of mass spectrometry analysis of proteins, free end users from the laborious and tedious multiple sample preparation steps, and allow near real-time and unambiguous detection of protein biomarkers, as well as therapeutics, drug targets, and more.

About VIC Foundry

VIC Foundry is one element of the VIC innovation ecosystem that includes VIC Tech, VIC Investor Network, and various associated programs such as the VIC Fellows. VIC Foundry develops technologies that have substantial potential impact and commercial promise but need additional development before private equity funding. VIC Foundry further develops promising technologies by accessing various grant funding opportunities. Upon successfully completing the given grant-funded project, a new company is formed, VIC places an initial executive team, and the VIC Investor Network makes a founding investment into the newly formed company. To learn more, visit vicfoundry.com

Share article on social media or email:

empty tomb’s Mission Match® Seeks to Counter “Interpretive Violence” Against Global Mothers


… more than 1 million children under the age of five die each year around the globe from preventable causes. So Mission Match is inviting churches to take action in Jesus’ name, and support these mothers.

empty tomb’s Mission Match believes that mothers in Africa and Asia, whose babies are dying from treatable causes, love their babies as much as other mothers do.

Therefore, Mission Match is offering matching money to churches whose projects help these mothers and their children in Jesus’ name.

“Interpretive Violence”

A 2008 study considered a theory currently debated among anthropologists. That theory proposes that a high level of child-death rates from preventable causes are due to mother neglect.

The study’s author concluded “the most common causes were infectious-contagious diseases (37.9%) and dehumanized care by the attending health professional (24.1%)” in the broader context of extreme poverty. The author continued, “To characterize a bereaved mother as ‘negligent,’ or worse, as accomplices in her child’s death, is an act of interpretive violence …”

The study concluded that “interpretative violence of perpetuating a mother-blame myth” allows others in a position to help prevent these deaths to be relieved of “co-responsibility for this human tragedy.”

Countering Interpretative Violence Against Global Mothers

Mission Match believes that mothers in Africa and Asia, whose babies are dying from treatable causes, love their babies as much as any mother does. Yet more than 1 million children under the age of five die each year around the globe from treatable causes.

So Mission Match is inviting churches to take action in Jesus’ name, and support these mothers.

Mission Match offers matching funds to historically Christian churches that have projects to assist global mothers and children. Mission Match focuses on mothers in 40 countries. These countries were not on track to meet global child-death reduction goals as of 2015.

The World Health Organization has listed 22 preventable causes of under-5 child deaths. Mission Match will match a church’s funds raised through member donations specifically for their project, up to $3,000. These projects are in one of the 40 countries and address at least one of the 22 preventable causes of death.

Churches can obtain more information and an application at missionmatch.org, on the Church Application page.

The 2008 study was authored by Marilyn K. Nations of the University of Forteleza, Brazil, and Harvard Medical School Department of Global Health and Social Medicine.

Share article on social media or email:

Announcing the Newest Member of the Olney, MD Chamber of Commerce


Men-in-Business

Newest Member of the Olney, MD Chamber of Commerce

“We are excited to have the Olney Center for Oral and Maxillofacial Surgery as a member of the Olney Chamber of Commerce. We appreciate their investment in our community.” – Terri Hogan, Executive Director of Olney Chamber of Commerce.

The Olney Center For Oral and Maxillofacial Surgery now proudly announces its membership in the Olney, MD Chamber of Commerce. The Olney Center For Oral and Maxillofacial Surgery strives to provide the highest quality, patient-centered surgical services in a safe and comfortable environment. With more than 20 years in the field, their goal is to achieve excellent results and exceed their patients’ expectations. Dr. Anis Tebyanian and his team are proud to become members of the Olney Chamber of Commerce.

“As a business owner, I understand how important it is to support other local businesses. Together, we can grow and help strengthen our community. I look forward to meeting the other community members in the future.” – Dr Anis Tebyanian, Owner, Olney Center For Oral and Maxillofacial Surgery.

The Olney Chamber of Commerce is dedicated to supporting, promoting and representing the business interests of its members. They acknowledge and honor their members’ business accomplishments and outstanding contributions. The Olney Chamber fosters the spirit of cooperation and understanding between all local professionals.

“We are excited to have the Olney Center for Oral and Maxillofacial Surgery as a member of the Olney Chamber of Commerce. We appreciate their investment in our community. They are a wonderful partner in helping our residents stay local and bringing business to our community for specialized services.” – Terri Hogan, Executive Director of Olney Chamber of Commerce.

The Olney Center For Oral and Maxillofacial Surgery offers a full scope of Oral and Maxillofacial Surgery, including wisdom-tooth extractions, placement of dental implants, full-mouth reconstruction, pathology of the oral and facial region, TMJ disorders, jaw surgery and facial-trauma surgery. Dr. Tebyanian is a board-certified Oral and Maxillofacial Surgeon. He is licensed as a dentist and a surgeon physician in the state of Maryland. He is trained in Anesthesia, General Surgery, Plastic Surgery, Head and Neck Surgery, Head and Neck Oncology and Trauma Surgery.

To learn more, contact Olney Center For Oral and Maxillofacial Surgery directly at 301-924-2155.

Share article on social media or email:

Central Florida Bonding Announces Their Newest Article Entitled, “What is Impaired Driving?”


alcohol, drugs and car keys

Many over the counter medications and prescription medications have side effects that include slower reaction times, decreased hand-eye coordination, difficulty concentrating or judging time and distance that are similar to the effects of alcohol and illegal drugs

Central Florida Bonding, located minutes from the Orange County Jail in Orlando, Florida launches their newest blog focused on educating people on what impaired driving means.

Hadi Khouri, the owner of Central Florida Bonding, states, “you could face driving under the influence charges after taking an over-the-counter medicine (OTC). Many OTC medications and prescription medications have side effects that include slower reaction times, decreased hand-eye coordination, difficulty concentrating or judging time and distance, and other impairments that are similar to the effects of alcohol and illegal drugs.”

Medications often include warning labels but if you aren’t certain, you should ask your doctor or pharmacist about potential side effects. These tips and more can be accessed online at: https://cfborlando.com/impaired-driving/

Khouri adds, that a new medication might affect you in ways you didn’t anticipate so always take precautions. Law enforcement officers are trained as drug recognition experts (DREs) to identify drug-impaired driving using a standardized evaluation that includes behavioral tests and physical assessments, such as breath alcohol testing, eye exams, and other behavioral and physical observations.

If there is sufficient evidence that the driver is impaired, drug recognition experts can collect blood or urine samples. Refusing to take a required roadside test at the time of arrest means your license will be automatically suspended for one full year.

After being arrested for DUI, you will likely receive a citation with instructions on how to complete the process. You must appear in court within 30 days of receiving the citation. If you fail to do so, you will be issued another citation and your license will be suspended until you pay the fine.

Khouri states “If you or a loved one finds themselves behind bars and facing charges of speeding, driving with a suspended license, driving under the influence, boating under the influence, reckless driving, or any other charge, Central Florida Bonding can help.”

Central Florida Bonding has bailed clients out of jail for numerous charges such as drugs, DUI, BUI, boating while intoxicated, driving while intoxicated, road rage, identity theft, domestic violence, child neglect, assault, battery, and more. To start the bail bond process, defendants are encouraged to call 407-841-3646. Central Florida Bonding is licensed to post bail throughout the state of Florida and with affiliated agencies across the United States.

A bail bond agent is available 24 hours a day, 7 days a week, and 365 days of the year. All of the bail bond agents at Central Florida Bonding are experienced, knowledgeable, and licensed. They are ready to assist with paperwork, can explain the ins and outs of the bail bond process, and can answer questions regarding the criminal justice system.

This Orlando bail bond agency serves all of Central Florida including Orange, Seminole, Osceola, Volusia, and Lake Counties. Defendants have benefited from the expertise of Central Florida Bonding since 1979. Khouri states, “We have been helping Central Floridians for many years. We can help you too! Please rely on our experience and expertise to guide you through this stressful experience.”

Central Florida Bonding is located in the Cox Plaza at 2911 39th Street, Suite 300, in Orlando, Florida. To learn more about this bail bond agency, visit online at https://cfborlando.com/, or call 407-841-3646.

Share article on social media or email:

Asymmetrex® Gives First Cell Culture Core Facility Introduction to Online Rapid Stem Cell Counting in the Institute for Applied Life Sciences at UMassAmherst


News Image

September 20 Presentation on Technology for Rapid Stem Cell Counting

After UMassAmherst in-person, the first national webinar in the core facility introduction series is scheduled a week later on September 27!

Outside of the world of laboratory science, one of the most significant group of contributors to the excellence of U.S. biomedical research is not that well known to most people. This often-understated group is made up of the directors and technical staff of research core facilities.

Research core facilities catalyze and accelerate the research pursued by their users by providing scientific and technical expertise with the use of high-end instruments and technologies that are usually too expensive and too complex for individual research laboratories to obtain and utilize effectively on their own. Core facility personnel also play an important role in achieving the teaching mission of research institutions to train the next generations of excellent biomedical investigators.

Because of this central role in stem cell medical research played by cell culture core facilities at major research institutions, Asymmetrex® selected them as the company’s first focus for introduction of its new online calculators for rapid counting of therapeutic tissue stem cells. The standard research services of cell culture core facilities, including growing and counting human tissue cells, integrate directly into Asymmetrex’s online portals for rapid stem cell counting.

Before Asymmetrex’s technology was available, there was no method for routine, convenient counting of tissue stem cells, which are always found in mixtures with other tissue cells that obscure them from identification and counting. The need for a method to quantify tissue stem cells has significantly held back both stem cell research and stem cell medicine for more than a half century. Asymmetrex’s counting technology is the first solution for this long-standing need for a means to monitor tissue stem cells in experiments and determine their dosage for more effective stem cell treatments.

Today, September 20, Asymmetrex President and CEO, James L. Sherley, M.D., Ph.D., is presenting the new counting technology to the users of the Cell Culture Core Facility in the Institute for Applied Life Sciences at the University of Massachusetts-Amherst. His presentation will be the first seminar in the current academic year for the IALS Core Facilities Seminar Series.

The UMassAmherst core facility was the ideal choice for Asymmetrex’s lead-off introduction to the capabilities and advantages of the new online stem cell calculators. Many of the validation studies for the new stem cell counting technology were performed by the UMassAmherst Cell Culture Core Facility under the direction of Michael P. Daley. Director Daley is one of the first core facility directors in the country who can now provide his users access to rapid counting of two different types of tissue stem cells widely used in stem cell research, umbilical cord blood stem cells and mesenchymal stem cells. In the future, through his core facility, faculty, students, trainees, and research staff at UMassAmherst will also be able to gain additional access to online calculators for counting many other types of important tissue stem cells used in their research.

Asymmetrex CEO Sherley has shared that he is looking forward to this first core facility introduction, which will be in-person. The company also plans a webinar series that will allow core facility directors anywhere in the U.S. to learn about doing what UMassAmherst has already started. “After UMassAmherst in-person, the first national webinar in the core facility introduction series is scheduled a week later on September 27!”

About Asymmetrex®

Asymmetrex®, LLC is a Massachusetts life sciences company with a focus on developing technologies to advance stem cell medicine. The company’s U.S. and U.K. patent portfolio contains biotechnologies that solve the two main technical problems – stem cell-specific quantification and stem cell expansion – that have stood in the way of more-effective use of human adult tissue stem cells for regenerative medicine and drug development. Asymmetrex markets kinetic stem cell (KSC) counting, the first technology for determination of the dose and quality of tissue stem cell preparations for use in stem cell transplantation medicine and pre-clinical drug evaluations. Asymmetrex® is a member company of the Advanced Regenerative Manufacturing Institute|BioFabUSA (ARMI) and the Massachusetts Biotechnology Council (MassBio). The company’s development of online calculators for rapid stem cell counting has been funded by R&D grants from ARMI|BioFabUSA and the National Heart, Lung, and Blood Institute.

Share article on social media or email:

Finally, a Clear Understanding of Copper’s Function” November 2 at SupplySide West 2022


News Image

We are looking forward to educating attendees on the key differences between Zinc and Copper, why companies are pursuing copper as an immune modulator and how copper works in animals and humans.

MitoSynergy®, a nutritional supplement company and home to the world’s first fully bioavailable copper supplement, is pleased to announce that it will hosting an educational lunch brief on November 2, 2022 from 1-2 p.m. in addition to exhibiting at SupplySide West 2022 at booth 6713 from October 31-November 4, 2022.

During the session, president and CEO of MitoSynergy, Charles Barker, will discuss the different variations of Copper, and how Copper II is not as beneficial to the human body as Copper I is. Copper II often finds its way to build up in the body and can have negative long-term effects. Attendees will learn how Copper I is an immune modulator that helps the body help itself by bringing a revolutionary copper chelate that can feed and charge the mitochondria.

“Copper and Zinc are found throughout the body and are essential for optimal immune system function. A deficiency in either of these can lead to an increased chance of sickness and/or bacterial infection,” said Barker. “We are looking forward to educating attendees on the key differences between Zinc and Copper, why companies are pursuing copper as an immune modulator and how copper works in animals and humans.”

For more information on MitoSynergy, visit http://www.MitoSynergy.com.

About MitoSynergy

MitoSynergy is a nutritional supplement company bringing consumers a better quality of life. Being the world’s first Copper (I) supplement, we have witnessed a direct impact on human energy producers the mitochondria. MitoSynergy started because of a loving uncle wanting to help his nephew that became paralyzed in his endeavors searching the world collaborating with top scientist and doctors to help his nephew the uncle stumbled across what led him to develop the world’s first Copper (I) Niacin.

Share article on social media or email:

ClinOne Hosts Expert Xtalks Webinar on Rare Disease Clinical Trials to Discuss the Caregiver Experience, Diversity Recruitment, and the Impact of Technology


News Image

Rare disease clinical trials are challenging on many levels. For example, how do you engage and ease the path for the patient and their caregivers so they can stay in the trial and maintain compliance? Our esteemed panel of experts will cover this critical issue and more. -ClinOne CEO Andrea Valente

ClinOne, the leading provider of Adaptive Experiences for clinical trial participants, continues its drive to make rare disease trials more accessible and impactful with an important discussion in a new Xtalks webinar.

On September 20 at 12pm ET, ClinOne CEO Andrea Valente will join expert panelists Daniel DeFabio, co-founder of the Disorder Channel, and Dr. Fabian Sandoval, President and CEO of the Emerson Clinical Research Institute. The conversation will cover essential topics such as the experience (and hope) for patients and caregivers in a rare disease trial, challenges ensuring diversity representation in patient recruitment, and how adaptive technology can help.

Xtalks: “Rare Disease Clinical Trials: Site, Advocate and Technology Insights”

Date and Time: Tuesday, September 20, 2022, 12-1pm EDT/5-6pm BST /6-7pm CEST

Register here

Attendees will gain insights into…

  • The realities, considerations and hope of rare disease clinical trials for families and caregivers
  • Challenges sites face finding and enrolling patients, especially when seeking diversity
  • Best practices and lessons learned for running and participating in rare disease trials
  • What Adaptive Experiences are, and how they can improve trials for all participants
  • Existing and new technologies that can have a positive impact on enrollment, retention and compliance

Featured Speakers

Daniel DeFabio (LinkedIn), Co-Founder of The Disorder Channel and Director of Community Engagement for Global Genes, and the parent of a child who had a rare disease, will share the realities of rare disease families – the expectations and hope, frustrations and challenges and the importance of maintaining a positive outlook when participating in a rare disease trial.

Fabian Sandoval MD (LinkedIn) President and CEO of the Emerson Clinical Research Institute, will focus on driving diversity in rare disease clinical trials and how to serve this community. Dr. Sandoval has 25+ years of bench to bedside research experience. His research career has included academia, healthcare systems and the public sector. He also hosts the Emmy-award winning TV program “Tu Salud Tu Familia” (Your Family Your Health).

Andrea Valente (LinkedIn), CEO of ClinOne, will share trends and solutions that consider the participant experience just as much as the data captured during a trial, and how study sponsors and sites can get the most out of them. She is a transformational leader and champion of adaptive experiences for clinical trial participants.

“Rare disease clinical trials are challenging on many levels,” Andrea Valente explained. “It is often very difficult to identify eligible patients. Participation is often especially hard for caregivers supporting their loved ones. Furthermore, trial costs routinely exceed $300k per patient. And, in many cases families know that a trial could be their last, best, or only hope for a loved one. So how do you engage and ease the path for the patient and their caregivers so they can stay in the trial and maintain compliance? I am excited for our esteemed panel of experts to cover these critical issues and more.”

Register here to join the complimentary webinar.

About ClinOne

ClinOne provides adaptive experiences for participants in clinical trials. By offering choice to patients, caregivers, and site staff, our technology makes it easier to stay active, compliant, and comfortable in a trial – thereby expanding enrollment access, reducing drop-out rate, and shortening conduct timelines. Our true single platform features solutions for local HCP trial awareness, remote and onsite eConsent, Uber Health, medication adherence, and a DCT portal. ClinOne stands alone with the industry’s fastest implementation (average 2-6 weeks), cost-efficient scale, and seamless API integrations for complex therapeutic areas such as Oncology, CNS, and Rare Disease in over 60 languages. To learn why more than 55 sponsors and CROs trust ClinOne in 100+ currently active studies to connect, inform, and empower participants to take control of their clinical trial experience, begin a conversation with our experts at http://www.clinone.com.

Share article on social media or email:

VA Maryland Health Care System Names a New Associate Director for Patient Care Services/Chief Nurse Executive


chief nurse executive, patient care services, VA Maryland Health Care System, VA healthcare

The VA Maryland Health Care System has named Diana Choi as its new Associate Director for Patient Care Services/Chief Nurse Executive.

“We are thrilled that Diana Choi is bringing her excellence and dedication to our team,” said Jonathan R. Eckman, P.E., director of the VA Maryland Health Care System

The VA Maryland Health Care System has named Diana Choi as its new Associate Director for Patient Care Services/Chief Nurse Executive. In this role, Choi is responsible for day-to-day operations of Nursing, Social Work and Sterile Processing Services for the health care system. She also is responsible for planning, coordinating and evaluating the operation of these services.

“We are thrilled that Diana Choi is bringing her excellence and dedication to our team,” said Jonathan R. Eckman, P.E., director of the VA Maryland Health Care System. “Her experience, versatility and commitment to patient care is crucial in helping us achieve our mission of providing safe, quality and compassionate care to veterans.”

Before joining the VA Maryland Health Care System, Choi served as the chief of clinics for the Department of Health & Human Services where she was responsible for the clinical operations for more than 228 health clinics and 300 federal agencies throughout the U.S. Prior to her federal service, she served as the executive director for LHC Group Inc., a publicly traded, national post-acute care provider. Choi also held positions of increasing responsibility as a patient care technician, critical care nurse and preceptor through the Johns Hopkins Hospital System. She has served as a senior adjunct professor in Nursing at Howard Community College since August 2015, where she was named Faculty Member of the Year in 2019.

“It is an honor to be a part of the VA Maryland Health Care System and to serve the needs of veterans every day,” Choi said. “I truly believe in the mission and vision of VA and look forward to working with our dynamic team to ensure that consistent, evidence-based care is delivered across our health care system.”

Choi received a Bachelor of Science in Nursing from Frostburg State University and a Master of Science in Nurse Education from Stevenson University. She is also the recipient of numerous awards, including the Federal Occupational Health Outstanding Service Award in 2020, among others.

She lives in Howard County.

# # #

The VA Maryland Health Care System (VAMHCS) provides a broad spectrum of medical, surgical, rehabilitative, mental health and outpatient care to veterans at three medical centers and five outpatient clinics located throughout the state. More than 52,000 veterans from various generations receive care from VAMHCS annually. Nationally recognized for its state-of-the-art technology and quality patient care, VAMHCS is proud of its reputation as a leader in veterans’ health care, research and education. It costs nothing for veterans to enroll for health care with the VA Maryland Health Care System and it could be one of the more important things a veteran can do. To enroll for VA health care, interested veterans can call 877-222-8387 Monday through Friday from 8 a.m. to 8 p.m., or they can visit http://www.va.gov and clinic on “Apply now for VA health care.”

Share article on social media or email: